Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03944798 · ClinicalTrials.gov registry record · NA
Surveillance AFter Extremity Tumor surgerY
A NA study of Soft Tissue Sarcoma and Lung Metastases, sponsored by McMaster University.
- Active
- Registry status
- NA
- Development phase
- 310
- Enrollment target
- 20
- Study locations
NCT03944798: Active NA study of Soft Tissue Sarcoma and Lung Metastases, sponsored by McMaster University.
NCT03944798 is a NA study of Soft Tissue Sarcoma and Lung Metastases that is active but no longer recruiting, run by McMaster University. The registered enrollment target is 310 participants, above the 73-participant average among 55 other Soft Tissue Sarcoma trials with a reported enrollment target (325% higher). The trial reports 20 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03944798, a NA study of Soft Tissue Sarcoma and Lung Metastases, is active but no longer recruiting, sponsored by McMaster University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
- 20
- Study locations
Study Summary
Following treatment for a primary extremity sarcoma, patients remain at risk for the development of local and systemic disease recurrence. Metastasis (distant recurrence) to the lung is the most frequent single location of disease recurrence in sarcoma patients, occurring in almost half of all patients. Therefore, careful post-operative surveillance is an integral element of patient care. However, the detection of metastases does not necessarily affect long-term survival and may negatively impact quality of life. Surveillance strategies have not been well researched and have been identified as the top research priority in the extremity sarcoma field. Using a 2X2 factorial design to maximize efficiency and reduce overall trial costs, the SAFETY trial randomized 310 extremity soft-tissue sarcoma (STS) patients to determine the effect of surveillance strategy on overall patient survival after surgery for a STS of the extremity by comparing the effectiveness of both surveillance frequency (every 3 vs. every 6 months) and imaging modality (CT scans vs. chest radiographs).
Primary Outcome
The composite outcome consists of overall survival, serious adverse events, and patient-reported cancer-related anxiety
Conditions Studied
Interventions
- OTHER Frequency: Every 3 Months
- OTHER Frequency: Every 6 Months
- OTHER Imaging Modality: Chest Radiograph (CXR)
- OTHER Imaging Modality: Chest CT
Study Locations (20)
New York
- Albany Medical Center - Albany
- NYU Langone Orthopaedic Hospital/Perlmutter Cancer Center - New York
- Montefiore Medical Center - The Bronx
Other
- Hospital Universitario Austral - Buenos Aires
- LKH - Universitätsklinikum Graz - Graz
- Cliniques Universitaires Saint-Luc - Brussels
California
- University of California Davis Medical Center - Sacramento
Connecticut
- Hartford HealthCare - Hartford
Florida
- University of Florida Health Shands Hospital - Gainesville
Illinois
- UChicago Medicine - Chicago
Indiana
- Parkview Cancer Institute - Fort Wayne
Iowa
- Holden Comprehensive Cancer Center - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2019-11-19 |
| Est. Completion | 2027-12 |
| Phase | NA |
What the registry record for NCT03944798 still lists
NCT03944798 is an interventional study that assigns participants to a tested intervention. The registered 310 participants enrollment target is mid-sized for trials with a published cap, above the 73-participant average among 55 other Soft Tissue Sarcoma trials with a reported enrollment target (325% higher).
The record links to 2 conditions, with Soft Tissue Sarcoma appearing as the primary indexed condition, and to 4 interventions - of which Frequency: Every 3 Months is the first listed.
NCT03944798 names 20 study sites across 16 states, led by New York, Other, California.
Frequently Asked Questions
What is clinical trial NCT03944798 about?
NCT03944798 is a clinical study titled "Surveillance AFter Extremity Tumor surgerY". Following treatment for a primary extremity sarcoma, patients remain at risk for the development of local and systemic disease recurrence. Metastasis (distant recurrence) to the lung is the most frequent single location of disease recurrence in sarcoma patients, occurring in almost half of all patie...
What is the current status of trial NCT03944798?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 310 participants. The study started on 2019-11-19. Estimated completion is 2027-12.
What conditions does trial NCT03944798 study?
This clinical trial studies the following conditions: Soft Tissue Sarcoma, Lung Metastases.
What interventions are being tested in trial NCT03944798?
The interventions under investigation include: Frequency: Every 3 Months (OTHER), Frequency: Every 6 Months (OTHER), Imaging Modality: Chest Radiograph (CXR) (OTHER), Imaging Modality: Chest CT (OTHER).
Who is sponsoring clinical trial NCT03944798?
This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03944798 being conducted?
This trial has 20 study locations across California, Connecticut, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Soft Tissue Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03944798's enrollment target sits among peer trials
310 3rd of 55 higher than 52 of 55 other Soft Tissue Sarcoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Soft Tissue Sarcoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise and Soft Tissue Sarcoma
RECRUITING · NA
-
Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma
RECRUITING · NA
-
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
RECRUITING · NA
-
68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas
RECRUITING · NA
-
Pre-operative Hypofractionated Proton Therapy
RECRUITING · NA
-
Feasibility Trial of Preoperative 5-Day Hypofractionated Radiotherapy for Primary Soft Tissue Sarcoma
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
- NCT04878094 · 310 participants · Phase 3
A Study of Intra-operative Imaging in Women With Ovarian Cancer
- NCT05459233 · 310 participants · NA
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI